Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangshen granule
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangshen granule is a traditional Chinese medicine (TCM) formula developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of pulmonary nodules, particularly ground-glass opacities, and as an adjuvant therapy for non-small cell lung cancer (NSCLC). The formulation is based on the TCM principle of "tonifying Qi and activating blood circulation" (Yi Qi Huo Xue), typically comprising *Radix Pseudostellariae* (Taizishen) and *Radix Salviae Miltiorrhizae* (Danshen). Pharmacological studies suggest that Shuangshen granule may inhibit tumor progression by modulating the immune microenvironment, suppressing angiogenesis through the inhibition of vascular endothelial growth factor (VEGF), and interfering with the PI3K/Akt signaling pathway to induce apoptosis and inhibit cell proliferation. It is currently utilized as a hospital-made preparation and is undergoing clinical evaluation in Phase 2 trials.
- Other names
- Shuangshen KeliShuang-Shen Granule
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on shuangshen granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangshen granule.